IGF-1 LR3
Long R3 IGF-1
A synthetic long-acting analog of insulin-like growth factor 1 with reduced binding to IGF-binding proteins, used as a research reagent. It acts as an IGF-1 receptor agonist, activating anabolic PI3K/Akt and MAPK signaling. Not approved for human use.
Half-life
~20-30 h reported (subcutaneous); some sources cite longer. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Lyophilized powder kept frozen or refrigerated and protected from light; reconstituted solutions refrigerated, used within a limited window.
References
- Francis et al. (Long-R3-IGF-I characterization)
Related in Cognitive / Longevity
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.